IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CNS Pharmaceuticals Inc

CUSIP: 18978H409 | 14 institutional holders

Quarters

Q1 2026Q4 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Sound Income Strategies, LLC16
0.0% of portfolio›$36
StyleTurnoverLocationFiled
Sound Income Strategies, LLC
16$360.0%YieldMediumFt Lauderdale, FL2026-04-27